Apollo Hospitals to Full Takeover of Apollo Health & Lifestyle

Apollo Hospitals to Full Takeover of Apollo Health & Lifestyle

India Pharma Outlook Team | Saturday, 13 September 2025

The healthcare chain Apollo Hospitals Entreprise Ltd said that it will pay Rs 1,254.07 crore to purchase the 31% share that International Finance Corporation had in its subsidiary Apollo Health and Lifestyle Ltd.The acquisition of slightly more than 41.65 crore equity shares, which together represent a 30.58 percent equity stake held jointly by the International Finance Corporation, Washington (IFC) and IFC EAF Apollo Investment Company (IFC EAF), in Apollo Health and Lifestyle Ltd (AHLL), was approved by the board of directors at its meeting on Friday, according to a regulatory filing from Apollo Hospitals Entreprise Ltd (AHEL).

After the proposed share purchase is completed, AHLL will be a 100% subsidiary of AHEL, with AHEL owning 99.42% of the company and the remaining portion in the ESOP pool.

According to the application, the goal of the acquisition is to gain complete control over AHLL's activities and consolidate ownership, which will improve operational efficiencies and allow for better integration with the company's diagnostic services.

Also Read: Aster DM Targets Tier-2 Cities to Challenge Apollo Hospitals' Lead

"This acquisition is a decisive step that will allow for sharper capital allocation and a greater focus on select high-potential segments. With disciplined growth, improved profitability, and enhanced return on capital employed (ROCE), we see AHLL becoming a value-accretive driver in Apollo's integrated healthcare portfolio," AHEL Managing Director Suneeta Reddy said.

"By bringing AHLL fully into Apollo's fold, we are sharpening the business focus across its four verticals-primary care and diagnostics, birthing and women's health, ambulatory care, and dialysis and dental. This sharper focus will enable AHLL to scale more effectively, innovate faster, and serve patients with care models that are more personalised, accessible, and future-ready," she added.

on the deck

Most Viewed

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.